Diabetes Kongress 2022
Kalender
Liste
Personen
Favoriten
zur Liste
Dr. Sebastian Pieperhoff
Novo Nordisk Pharma GmbH
Germany
Vortrag
Once-Weekly Semaglutide 1 mg vs Empagliflozin 25 mg as Add-On to Metformin Monotherapy in Patients with Type 2 Diabetes: a Meta-Regression Analysis of Individual Patient Data
Speaker
Datum: 26.05.2022 , Zeit: 14:14
|
Thema: Poster
Details
Vortrag
Real-world use of once-weekly semaglutide in type 2 diabetes: results from SURE Germany
Autor:in
Datum: 27.05.2022 , Zeit: 11:47
|
Thema: Poster
Details